Digital Exclusives
A new breed of price gouging pharmaceutical companies is facing public outrage from consumers—and spurring discourse on drug pricing in the process.
Health care reform has led drugmakers and hospital systems to carry out more rigorous cost-benefit value analyses. Take the experience of two alumni at BD and Valley Health System.
